☰

Srinivas R. Nandana, Ph.D. - Publications

Affiliations: 
2010 Vanderbilt University, Nashville, TN 
Area:
Cell Biology, Oncology
Tree Info Grants Similar researchers PubMed Report error

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Tharp D, Nandana S. How Prostate Cancer Cells Use Strategy Instead of Brute Force to Achieve Metastasis. Cancers. 11: 1928. PMID 31817000 DOI: 10.3390/Cancers11121928  0.572
2019 Chu GC, Chung LWK, Gururajan M, Hsieh CL, Josson S, Nandana S, Sung SY, Wang R, Wu JB, Zhau HE. Regulatory signaling network in the tumor microenvironment of prostate cancer bone and visceral organ metastases and the development of novel therapeutics. Asian Journal of Urology. 6: 65-81. PMID 30775250 DOI: 10.1016/J.Ajur.2018.11.003  0.571
2019 Tripathi M, Nandana S, Huang J, Kato M, Mishra R, Chung L, Xin L, Bhowmick N. Abstract 5164: Signaling crosstalk within prostate tumor microenvironment mediates castrate resistant disease progression Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-5164  0.529
2019 Nandana S, Gururajan M, Tripathi M, Chu C, Zhau H, Shiao S, Chung L. Abstract 4523: A novel syngeneic mouse model of prostate cancer bone metastasis: Mechanisms of chemotaxis and bone colonization Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-4523  0.613
2017 Tripathi M, Nandana S, Billet S, Cavassani KA, Mishra R, Chung LWK, Posadas EM, Bhowmick NA. Modulation of cabozantinib efficacy by the prostate tumor microenvironment. Oncotarget. 8: 87891-87902. PMID 29152128 DOI: 10.18632/Oncotarget.21248  0.538
2017 Nandana S, Tripathi M, Duan P, Chu CY, Mishra R, Liu C, Jin R, Yamashita H, Zayzafoon M, Bhowmick NA, Zhau HE, Matusik RJ, Chung LW. Bone metastasis of prostate cancer can be therapeutically targeted at the TBX2-WNT signaling axis. Cancer Research. PMID 28108510 DOI: 10.1158/0008-5472.Can-16-0497  0.707
2016 Tripathi M, Nandana S, Huang J, Kato M, Chung LWK, Mishra R, Xin L, Bhowmick N. Abstract PR06: Reciprocal prostate cancer signaling with its microenvironment mediates castrate-resistant disease progression Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-Pr06  0.655
2016 Tripathi M, Nandana S, Billet S, Posadas EM, Chung LWK, Bhowmick NA. Abstract LB-274: Microenvironment mediates the efficacy of Cabozantinib in prostate cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-274  0.709
2016 Nandana S, Tripathi M, Duan P, Chu G, Zhau HE, Matusik RJ, Chung LWK. Abstract 4131: Blocking endogenous TBX2 abrogates prostate cancer bone metastasis through WNT signaling Cancer Research. 76: 4131-4131. DOI: 10.1158/1538-7445.Am2016-4131  0.73
2015 Gururajan M, Cavassani KA, Sievert M, Duan P, Lichterman J, Huang JM, Smith B, You S, Nandana S, Chu GC, Mink S, Josson S, Liu C, Morello M, Jones LW, et al. SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer. Oncotarget. PMID 26624980 DOI: 10.18632/Oncotarget.6398  0.609
2014 Nandana S, Chung LW. Prostate cancer progression and metastasis: potential regulatory pathways for therapeutic targeting. American Journal of Clinical and Experimental Urology. 2: 92-101. PMID 25374910  0.533
2014 Josson S, Gururajan M, Hu P, Shao C, Chu GY, Zhau HE, Liu C, Lao K, Lu CL, Lu YT, Lichterman J, Nandana S, Li Q, Rogatko A, Berel D, et al. miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4636-46. PMID 24963047 DOI: 10.1158/1078-0432.Ccr-14-0305  0.568
2013 Nandana S, Tripathi M, Gururajan M, Chu G, Matusik RJ, Chung LWK. Abstract C23: Blocking endogenous TBX2 expression abrogates prostate cancer bone metastasis in a xenograft mouse model Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-C23  0.743
2010 Nandana S, Ellwood-Yen K, Sawyers C, Wills M, Weidow B, Case T, Vasioukhin V, Matusik R. Hepsin cooperates with MYC in the progression of adenocarcinoma in a prostate cancer mouse model. The Prostate. 70: 591-600. PMID 19938013 DOI: 10.1002/Pros.21093  0.72
2009 Yi Y, Nandana S, Case T, Nelson C, Radmilovic T, Matusik RJ, Tsuchiya KD. Candidate metastasis suppressor genes uncovered by array comparative genomic hybridization in a mouse allograft model of prostate cancer. Molecular Cytogenetics. 2: 18. PMID 19781100 DOI: 10.1186/1755-8166-2-18  0.657
2008 Tripathi M, Nandana S, Yamashita H, Ganesan R, Kirchhofer D, Quaranta V. Laminin-332 is a substrate for hepsin, a protease associated with prostate cancer progression. The Journal of Biological Chemistry. 283: 30576-84. PMID 18784072 DOI: 10.1074/Jbc.M802312200  0.694
2008 Matusik RJ, Jin RJ, Sun Q, Wang Y, Yu X, Gupta A, Nandana S, Case TC, Paul M, Mirosevich J, Oottamasathien S, Thomas J. Prostate epithelial cell fate. Differentiation; Research in Biological Diversity. 76: 682-98. PMID 18462434 DOI: 10.1111/J.1432-0436.2008.00276.X  0.672
2008 Levitin F, Weiss M, Hahn Y, Stern O, Papke RL, Matusik R, Nandana SR, Ziv R, Pichinuk E, Salame S, Bera T, Vincent J, Lee B, Pastan I, Wreschner DH. PATE gene clusters code for multiple, secreted TFP/Ly-6/uPAR proteins that are expressed in reproductive and neuron-rich tissues and possess neuromodulatory activity. The Journal of Biological Chemistry. 283: 16928-39. PMID 18387948 DOI: 10.1074/Jbc.M801454200  0.617
Show low-probability matches.